Acquisition - November 11, 2021
Organon acquires Forendo Pharma
The global pharmaceutical company Organon is acquiring its portfolio company Forendo Pharma. Forendo Pharma’s shareholders will receive an initial payment of USD 75 million and are entitled to additional future payments totaling USD 870 million upon the achievement of certain development, registration and commercial milestones pertaining to Forendo Pharma’s drug candidates. The total purchase price, […]
Financing - August 2, 2019
EUR 5 million investment in Forendo Pharma
Sunstone Life Science Ventures makes a €5 million investment into the Finnish women’s health company Forendo Pharma to finance clinical studies in endometriosis. Sunstone has announced its first investment out of its Life Science Ventures Fund IV into Forendo Pharma, a Finnish clinical stage drug development company focusing on novel treatments in women’s health. The […]